SP-DTI: subpocket-informed transformer for drug-target interaction prediction.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39798127.
- Also identified by DOI 10.1093/bioinformatics/btaf011 and PMC identifier 11886779.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Drug-target interaction (DTI) prediction is crucial for drug discovery, significantly reducing costs and time in experimental searches across vast drug compound spaces. While deep learning has advanced DTI prediction accuracy, challenges remain: (i) existing methods often lack generalizability, with performance dropping significantly on unseen proteins and cross-domain settings; and (ii) current molecular relational learning often overlooks subpocket-level interactions, which are vital for a detailed understanding of binding sites. We introduce SP-DTI, a subpocket-informed transformer model designed to address these challenges through: (i) detailed subpocket analysis using the Cavity Identification and Analysis Routine for interaction modeling at both global and local levels, and (ii) integration of pre-trained language models into graph neural networks to encode drugs and proteins, enhancing generalizability to unlabeled data. Benchmark evaluations show that SP-DTI consistently outperforms state-of-the-art models, achieving an area under the receiver operating characteristic curve of 0.873 in unseen protein settings, an 11% improvement over the best baseline. The model scripts are available at https://github.com/Steven51516/SP-DTI.
Medical subject headings
- Drug Discovery
- Proteins
- Computational Biology